PRODUCT CLASSIFICATION
Glycoprotein Cytokine
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Drogsan
WAREHOUSE
International Warehouse 2
ACTIVE SUBSTANCE
Erythropoietin
Introducing Dropoetin, a medically approved treatment specifically designed for managing anemia related to chronic renal failure in both pediatric and adult patients undergoing hemodialysis and peritoneal dialysis. This powerful formulation is also indicated for adults experiencing severe renal-origin anemia, even before dialysis is necessary.
Dropoetin serves as a critical therapy for adult cancer patients (excluding those with myeloid malignancies) undergoing chemotherapy, helping to alleviate anemia and decrease the need for blood transfusions. Moreover, it is beneficial for adults with HIV on zidovudine, particularly those with endogenous Dropoetin levels at or below 500 mU/ml.
In preparation for major elective surgeries, Dropoetin can support autologous blood collection for patients with moderate anemia (hematocrits of 33-39% and hemoglobin levels between 10-13 g/dL), especially when significant blood loss is anticipated. This treatment is essential when blood-saving techniques are inadequate or unavailable.
Dropoetin also enhances erythropoiesis during the perioperative period, reducing the necessity for allogeneic blood transfusions and effectively addressing postoperative anemia in adult patients who lack access to an autologous donation program.
For patients diagnosed with Low or Intermediate 1-risk Myelodysplastic Syndrome (MDS) and hemoglobin levels below 10 g/dL, Dropoetin is an effective treatment option.
How to Use Dropoetin:
Administer Dropoetin precisely as directed by your physician. Always refer to the medication label for personalized dosing instructions. A detailed Medication Guide is included with Dropoetin; please read it thoroughly before every refill.
Typically, Dropoetin is administered as an injection by a healthcare provider in a clinical setting. If you are using it at home, your healthcare professional will provide comprehensive instructions on proper administration. Ensure you fully understand the process and do not hesitate to reach out to your provider with any questions.
When preparing your dose, follow the guidelines provided to prevent contamination of the vial, syringe, or medication. Avoid direct contact with the rubber stopper of the vial and the syringe needle. Always verify that you have the correct dose before administering.
Do not shake Dropoetin, and avoid using it if it has been shaken or frozen. Never dilute or mix Dropoetin with other solutions unless specifically instructed by your doctor. For single-dose vials, dispose of any leftover medication after your dose. Consult your healthcare provider if you have questions regarding the disposal of single-dose vials.
Keep Dropoetin, along with syringes and needles, safely out of reach of children and pets. Do not reuse needles or syringes, and inquire about proper disposal methods with your healthcare provider. Adhere to all local regulations regarding disposal.
Continue using Dropoetin consistently, even if you feel well, and do not skip doses. If you miss a dose, contact your doctor immediately.
If you have any questions about using Dropoetin, please feel free to reach out to your healthcare provider.
Potential Side Effects of Dropoetin:
While serious side effects are addressed in other sections of the label, please be aware of the following:
- Increased risk of mortality, myocardial infarction, stroke, and thromboembolism
- Elevated mortality risks or potential tumor progression/recurrence in cancer patients
- Hypertension
- Seizures
- Pure Red Cell Aplasia (PRCA)
- Severe allergic reactions